US 6685941
Methods of treating autoimmune disease via CTLA-4Ig
expired A61KA61K2039/505A61K2239/31
Quick answer
US patent 6685941 (Methods of treating autoimmune disease via CTLA-4Ig) held by United States of America as represented by the Secretary of the Air Force expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/48